Today: 19 July 2026
Salesforce stock slides 4% to start 2026 — CRM investors brace for jobs data and earnings

Salesforce stock slides 4% to start 2026 — CRM investors brace for jobs data and earnings

NEW YORK, January 3, 2026, 05:51 ET — Market closed

  • Salesforce shares fell 4.26% in the first session of 2026, closing at $253.62
  • Software peers also slid, even as chipmakers helped lift the Dow and S&P 500
  • Focus turns to U.S. jobs and inflation data, then Salesforce’s next earnings update

Salesforce (CRM) shares closed down 4.26% at $253.62 on Friday, marking a weak start to 2026 for the cloud software bellwether. ServiceNow and DocuSign also fell, underscoring broader pressure across enterprise software.

The drop came as the Dow and S&P 500 ended higher, helped by a rally in chipmakers, while some big technology names retreated, Reuters reported. “Investors might be a little bit more conscious about some of the valuations that they’re paying for some of the AI plays,” said Joe Mazzola, head of trading and derivatives strategist at Charles Schwab. Reuters

That split matters for Salesforce because the stock trades as an “AI in the enterprise” proxy as well as a core cloud-software holding. When investors rotate around valuations, higher-multiple software can move sharply even without fresh company-specific headlines.

Salesforce sells customer relationship management (CRM) software — tools that help companies track sales leads and manage customer data — largely through subscriptions. That business model can make the stock sensitive to shifts in expectations for corporate IT spending and interest rates.

In its most recent quarterly report in December, Salesforce raised its full-year fiscal 2026 revenue guidance to $41.45 billion to $41.55 billion and said its Agentforce and Data 360 annual recurring revenue hit nearly $1.4 billion. Annual recurring revenue (ARR) is a run-rate measure of subscription sales.

Investors have been watching whether that AI-driven momentum shows up in bookings and margins, especially after the company leaned on share repurchases and dividends to return cash and support earnings per share.

Before next session: A busy January calendar could test equity valuations, with U.S. employment data due Jan. 9 and the consumer price index report due Jan. 13, Reuters reported. Fourth-quarter earnings season also ramps up in mid-January, starting with major U.S. banks.

Salesforce has not confirmed its next earnings publication date, but MarketBeat’s calendar estimates the company will report fourth-quarter results on Feb. 25 after the close. Investors will be looking for updates on demand signals, AI product traction, and guidance for the next fiscal year.

On the chart, Salesforce ended Friday about 1.5% above its 50-day moving average and about 1.3% below its 200-day moving average, according to Finviz data. A moving average is the average closing price over a set number of sessions and is commonly used as a rough trend gauge; those readings imply the 50-day line sits near $250 while the 200-day line is around $257.

That puts the $250 area in focus as a near-term support zone for traders, with $257 acting as an overhead marker after the selloff. A rebound back toward the low-$260s would ease some of the immediate downside pressure.

Beyond charts, portfolio managers will be scanning early earnings reports for read-through on corporate software budgets and whether AI add-ons are expanding deal sizes. Any shift in rate expectations tied to next week’s data could also feed directly into software valuations.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Molina Healthcare: Market Sentiment Misses the Mark
    July 19, 2026, 6:19 AM EDT. The market's reading of Molina Healthcare's valuation appears mistaken, opening a window for investors. An independent finance expert, experienced in macroeconomic analysis, technical patterns, and momentum-driven trading, makes the case that shares are currently undervalued. The analyst's method prioritises capital protection and a favourable risk-reward profile, blending Growth At A Reasonable Price (GARP) with momentum strategies for a balanced investment framework. The article highlights Molina Healthcare's prospects with actionable, data-backed observations in a turbulent market, encouraging investors to reassess the cautious outlook now prevailing.
UnitedHealth stock rises today as 2026 opens; UNH holds gains after hours with earnings ahead
Previous Story

UnitedHealth stock rises today as 2026 opens; UNH holds gains after hours with earnings ahead

Blackbaud stock slides nearly 6% to start 2026 as investors eye jobs data and mid-Feb earnings window
Next Story

Blackbaud stock slides nearly 6% to start 2026 as investors eye jobs data and mid-Feb earnings window

Go toTop